Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2001-11-16
2011-10-04
Navarro, Albert (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007320, C435S007400, C435S029000
Reexamination Certificate
active
08030002
ABSTRACT:
Methods for aiding in the diagnosis of disorders including, but not limited to, PDDs (Pervasive Development Disorders), Dysautonomic disorders, Parkinson's disease and SIDS (Sudden Infant Death Syndrome). In one aspect, a diagnosis method comprises analyzing a stool sample of an individual for the presence of a biological marker (or marker compound) comprising one or more pathogens, which provides an indication of whether the individual has, or can develop, a disorder including, but not limited to, a PDD, Dysautonomia, Parkinsons disease and SIDS. Preferably, the presence of one or more pathogens is determined using a stool immunoassay to determine the presence of antigens in a stool sample, wherein such antigens are associated with one or more pathogens including, but not limited to,Giardia, Cryptosporidium, E. histolytica, C. difficile, Adenovirus, Rotavirus orH. pylori.
REFERENCES:
patent: 3002883 (1961-10-01), Butt et al.
patent: 3223594 (1965-12-01), Hoek et al.
patent: 3357894 (1967-12-01), Uriel et al.
patent: 3515642 (1970-06-01), Mima et al.
patent: 3574819 (1971-04-01), Gross et al.
patent: 3940478 (1976-02-01), Kurtz
patent: 4079125 (1978-03-01), Sipos
patent: 4145410 (1979-03-01), Sears
patent: 4241046 (1980-12-01), Papahadjopoulos et al.
patent: 4826679 (1989-05-01), Roy
patent: 5190775 (1993-03-01), Klose
patent: 5250418 (1993-10-01), Moller et al.
patent: 5324514 (1994-06-01), Sipos
patent: 5436319 (1995-07-01), Kung et al.
patent: 5437319 (1995-08-01), Garuglieri
patent: 5439935 (1995-08-01), Rawlings et al.
patent: 5460812 (1995-10-01), Sipos
patent: 5476661 (1995-12-01), Pillai et al.
patent: 5527678 (1996-06-01), Blaser et al.
patent: 5585115 (1996-12-01), Sherwood et al.
patent: 5607863 (1997-03-01), Chandler
patent: 5648335 (1997-07-01), Lewis et al.
patent: 5674532 (1997-10-01), Atzl et al.
patent: 5686311 (1997-11-01), Shaw
patent: 5750104 (1998-05-01), Sipos
patent: 5776917 (1998-07-01), Blank et al.
patent: 5858758 (1999-01-01), Hillman et al.
patent: 5952178 (1999-09-01), Lapidus et al.
patent: 5958875 (1999-09-01), Longo et al.
patent: 5985891 (1999-11-01), Rowe
patent: 6011001 (2000-01-01), Navia et al.
patent: 6013286 (2000-01-01), Klose
patent: 6020310 (2000-02-01), Beck et al.
patent: 6020314 (2000-02-01), McMichael
patent: 6153236 (2000-11-01), Wu et al.
patent: 6187309 (2001-02-01), McMichael et al.
patent: 6197746 (2001-03-01), Beck et al.
patent: 6210950 (2001-04-01), Johnson et al.
patent: 6251478 (2001-06-01), Pacifico et al.
patent: 6261613 (2001-07-01), Narayanaswamy et al.
patent: 6280726 (2001-08-01), Weinrauch et al.
patent: 6309669 (2001-10-01), Setterstrom et al.
patent: 6399101 (2002-06-01), Frontanes et al.
patent: 6482839 (2002-11-01), Thornfeldt
patent: 6534063 (2003-03-01), Fallon
patent: 6534259 (2003-03-01), Wakefield
patent: 6632429 (2003-10-01), Fallon
patent: 6660831 (2003-12-01), Fallon
patent: 6727073 (2004-04-01), Moore et al.
patent: 6743447 (2004-06-01), Labergerie et al.
patent: 6797291 (2004-09-01), Richardson
patent: 6835397 (2004-12-01), Lee et al.
patent: 6852487 (2005-02-01), Barany et al.
patent: 7101573 (2006-09-01), Szymczak et al.
patent: 7129053 (2006-10-01), Reiter et al.
patent: 7138123 (2006-11-01), Fallon
patent: 2002/0037284 (2002-03-01), Fallon
patent: 2002/0090653 (2002-07-01), Fallon
patent: 2003/0097122 (2003-05-01), Ganz et al.
patent: 2004/0057944 (2004-03-01), Galle et al.
patent: 2004/0057962 (2004-03-01), Timmerman
patent: 2004/0071683 (2004-04-01), Fallon
patent: 2004/0076590 (2004-04-01), Wilkins, Jr.
patent: 2004/0101562 (2004-05-01), Maio
patent: 2004/0121002 (2004-06-01), Lee et al.
patent: 2004/0209790 (2004-10-01), Sava et al.
patent: 2005/0187130 (2005-08-01), Brooker et al.
patent: 2006/0105379 (2006-05-01), Wu et al.
patent: 2006/0182728 (2006-08-01), Fallon
patent: 2006/0183180 (2006-08-01), Fallon
patent: 2006/0198838 (2006-09-01), Fallon
patent: 2006/0259995 (2006-11-01), Cayouette et al.
patent: 2007/0053895 (2007-03-01), Fallon
patent: 2007/0116695 (2007-05-01), Fallon
patent: 2008/0058282 (2008-03-01), Fallon
patent: 2008/0152637 (2008-06-01), Fallon
patent: 2008/0161265 (2008-07-01), Fallon et al.
patent: 2008/0166334 (2008-07-01), Fallon
patent: 2008/0219966 (2008-09-01), Fallon
patent: 2008/0254009 (2008-10-01), Finegold
patent: 2008/0279839 (2008-11-01), Schuler et al.
patent: 2008/0317731 (2008-12-01), Gramatikova et al.
patent: 2009/0130081 (2009-05-01), Fallon
patent: 2009/0197289 (2009-08-01), Fallon
patent: 2009/0232789 (2009-09-01), Fallon
patent: 2009/0263372 (2009-10-01), Fallon
patent: 2009/0285790 (2009-11-01), Fallon
patent: 2009/0286270 (2009-11-01), Fallon
patent: 2009/0324572 (2009-12-01), Fallon
patent: 2009/0324730 (2009-12-01), Fallon
patent: 2010/0092447 (2010-04-01), Fallon
patent: 2010/0169409 (2010-07-01), Fallon et al.
patent: 2010/0233218 (2010-09-01), Fallon
patent: 2010/0260857 (2010-10-01), Fallon et al.
patent: 43 32 985 (1995-03-01), None
patent: 0 451 484 (1991-10-01), None
patent: 0 564 739 (2000-01-01), None
patent: 2 347 742 (2000-09-01), None
patent: 2 347 742 (2000-09-01), None
patent: 62-230714 (1987-10-01), None
patent: WO 95/22344 (1995-08-01), None
patent: WO 98/22499 (1998-05-01), None
patent: WO 98/52593 (1998-11-01), None
patent: WO 99/64059 (1999-12-01), None
patent: WO 00/09142 (2000-02-01), None
patent: 01/27612 (2001-04-01), None
patent: WO 01/43764 (2001-06-01), None
patent: WO 02/14537 (2002-02-01), None
patent: WO 02/14537 (2002-05-01), None
patent: WO 2009/114757 (2009-09-01), None
patent: WO 2010/002972 (2010-01-01), None
patent: WO 2010/080830 (2010-07-01), None
patent: WO 2010/080835 (2010-07-01), None
Parisi et al., “Evaluation of New Rapid Commercial Enzyme Immunoassay for Detection of Cryptosporidium Oocysts in Untreated Stool Specimens,” J. Clin. Microbiol., vol. 33(7), pp. 1963-1965 (1995).
Dobbs et al., “Link betweenHelicobacter pyloriInfection and Idiopathic Parkinsonism,” Medical hypothesis, vol. 55(2), pp. 93-98 (2000).
Tsang et al., “Extragastroduodenal conditions assocaited withHelicobavter pyloriinfection”, Hong Kong Medical Journal, vol. 5(2), pp. 169-174 (1999).
Cruse et al. illustrated Dictionary of Immunology, CRC Press, New York 1995.
Woodward et al., “Ischaemic enterocolitis complicating idiopathic dysatuonomia,” Gut 43: 285-287 (1998).
Koster et al., “Evidence based medicine and extradigenstive manifestations ofHelicobacter pylori,” Acta Gastro-Enterologica Belgica, vol. 63(4), pp. 388-392 (2000).
Mesh Browser, “Child Development Disorders, Pervasive,” and “Attentiaon Deficit and Disruptive Behavior Disorders,” http://www.nlm.nih.gov/mesh/2002/MBrowser.html, National Library of Medicine, 2001.
Finegold et al., Clinical Infectious Diseases, vol. 35 (Supp 1), pp. S6-15 (2002).
Filipek et al., “The screening and diagnosis of autistic spectrum disorders.,” Journal of autism and developmental disorders, vol. 29 No. 6, pp. 439-484 (Dec. 1999).
Happe et al., “The neuropsychology of autism.,” Brain, vol. 119 No. 4, pp. 1377-1400 (1996).
Skeels et al, 1990, vol. 80, pp. 305-308, American Journal of Public Health.
Nevo et al, 1997, The Journal of Infectious Diseases, vol. 176(Suppl2), pp. S154-S156.
Peters et al 1986, Journal of Clinical Microbiology, vol. 24(4), Oct. 1986, pp. 684-685.
Garcia et al, 2000, vol. 38(9) Journal of Clinical Microbiology, Sep. 2000, pp. 3337-3340.
Sandler et al, 2000, Journal of Child Neurology, Jul. 2000, vol. 15(7), pp. 429-435, Short term benefit from Oral Vancomycin Treatment of Regressive-Onset Autism.
U.S. Appl. No. 09/929,592, filed Aug. 14, 2001 entitled: Methods for Diagnosing and Treating Dysautonomia and Other Dysautonomic Conditions.
U.S. Appl. No. 09/466,559, filed Dec. 17, 1999 entitled: Methods for Treating Pervasive Development Disorders.
U.S. Appl. No. 09/707,395, filed Nov. 7, 2000 entitled: Methods for Treating Pervasive Development Disorders.
“Correlation between protein intake and daily levodopa dosage,” Azilect/Rasagiline, Obt
Curemark LLC
Navarro Albert
Wilson Sonsini Goodrich & Rosati
LandOfFree
Methods for diagnosing pervasive development disorders,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagnosing pervasive development disorders,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosing pervasive development disorders,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4261094